Search for: "KING PHARMACEUTICALS, INC."
Results 81 - 100
of 211
Sorted by Relevance
|
Sort by Date
11 Mar 2013, 12:49 pm
Mar. 5, 2013), the plaintiffs were qui tam relators who’d sparked investigations by state AGs into alleged False Claims Act violations by the pharmaceutical manufacturer, Abbot Products, Inc., which was later acquired by Solvay Pharmaceuticals, Inc.. [read post]
11 Jan 2008, 9:00 am
: (Biotech Weblog),Immunomedics obtains antibody patent: (SmartBrief),Cyplasin Biomedical obtains US patent for protein based cancer treatment: (Patent Docs)Argatroban - Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v… [read post]
16 Nov 2007, 4:00 am
: (LawFont),BrazilBrazil pays the price for compulsory licensing: (IAM), (Generic Pharmaceuticals & IP), CanadaThe Chronicle reports that Honourable Mr. [read post]
20 Sep 2017, 7:11 am
Solvay Pharmaceuticals, Inc., No. 16-20259 (5th Cir. [read post]
20 Sep 2017, 7:11 am
Solvay Pharmaceuticals, Inc., No. 16-20259 (5th Cir. [read post]
20 Sep 2017, 7:11 am
Solvay Pharmaceuticals, Inc., No. 16-20259 (5th Cir. [read post]
8 Feb 2017, 3:09 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
30 Mar 2011, 9:14 am
And the only U.S. manufacturer of the drug, Hospira Inc. [read post]
1 Dec 2007, 9:00 am
pharmaceutical companies: (SpicyIP),Great discussion on pharmaceuticals, patents and incentives for innovation: (Generic Pharmaceuticals & IP), (DrugWonks),Adenoscan (Adenosine) - Astellas Pharma, King Pharmaceuticals, and Teva Settle Adenoscan ® Patent Suit: (PatentDocs), Clarinex (Desloratadine) - Schering Corp. adds Anchen Pharmaceuticals Inc. to the long list of companies sued for patent infringement: (IPLaw360),… [read post]
14 Jun 2011, 12:21 pm
Teva Pharmaceuticals USA, Inc., 10-1070, in which the Court had relisted twice and called for a response. [read post]
16 Jan 2017, 5:44 pm
Teva Pharmaceuticals USA, Inc., et al. [read post]
9 Mar 2011, 3:00 am
Bayer AG (FDA Law Blog) (Patent Docs) Dexilant (Dexlansoprazole) – US: Takeda files patent infringement suit against Handa following Para IV certification filing (Patent Docs) EpiPen – US: Orange Book patent delisting counterclaim raised in 505(b)(2) application patent infringement litigation; decision could provide guidance on drug delivery system patent listability: King Pharmaceuticals v Intelliject (FDA Law Blog) Fentora (Fentanyl) – US: Cephalon… [read post]
14 Nov 2016, 9:16 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
25 Jan 2010, 5:00 am
See Basic, Inc. v. [read post]
13 Oct 2016, 6:50 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
9 Aug 2011, 7:03 pm
” The court in this decision stated that it was “not persuaded by the reasoning set forth in King Bio Pharmaceuticals that inclusion in the HPUS is sufficient to guarantee the efficacy and safety of a homeopathic OTC drug. [read post]
17 Feb 2010, 5:10 am
USA, Inc; Eli Lilly & Co. v. [read post]
2 Mar 2015, 2:24 pm
The challengers in King v. [read post]
18 Aug 2011, 12:56 pm
©2011 Amaxx Risk Solutions, Inc. [read post]
10 Mar 2011, 3:23 pm
©2011 Amaxx Risk Solutions, Inc. [read post]
